To further evaluate the effects of TFP on autophagic flux, we treated PAH-PASMCs with TPF in the presence of chloroquine (CQ, a well-established end-stage autophagic flux inhibitor blocking the fusion of autophagic vesicles and lysosomes) and examined the effect on LC3 expression. Here, MAP1LC3A is linked to pulmonary arterial hypertension.